Tyler Zeronda reports a stock award at Yarrow Bioscience

By AlphaYouPublished Oct 30, 2026Form 4

Stocks in this disclosure

Reported activity

Zeronda Tyler

Reporting filer

Tyler Zeronda reports a stock award, not an open-market purchase or sale, in Yarrow Bioscience, Inc.. Form 4 filed Oct 30, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Option (Right to Buy) (derivative)	Zeronda Tyler	2026-10-29	A	Grant or award	156115	0	156,115	1 day	Filed terms security Title: Stock Option (Right to Buy) conversion Or Exercise Price: 20 transaction Date: 2026-10-29 deemed Execution Date: transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 156115 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-10-29 underlying Security Title: Common Stock underlying Security Shares: 156115 shares Owned Following Transaction: 156115 direct Or Indirect Ownership: D

Owner: Zeronda Tyler
Date: 2026-10-29
Code: A
Action: Grant or award
Quantity: 156115
Price: 0
Following holdings: 156,115
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Stock Option (Right to Buy)
conversion Or Exercise Price: 20
transaction Date: 2026-10-29
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 156115
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-10-29
underlying Security Title: Common Stock
underlying Security Shares: 156115
shares Owned Following Transaction: 156115
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Zeronda Tyler: Chief Financial Officer.
F1: This option represents a right to purchase 156,115 shares of the Issuer's common stock, one quarter of which will vest on July 28, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Prepared automatically from public filing data. Report a correction.